These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7624004)

  • 21. Beta 2-microglobulin, amyloidosis, and dialysis.
    Acchiardo S
    Int J Artif Organs; 1988 Jul; 11(4):229-31. PubMed ID: 3045017
    [No Abstract]   [Full Text] [Related]  

  • 22. Colonic pseudo-obstruction due to beta2-microglobulin amyloidosis after long-term haemodialysis.
    Bruno MJ; van Dorp WT; Ferwerda J; Dekker W; Schut NH
    Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):717-20. PubMed ID: 9744704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dialysis-related amyloidosis and acquired renal cystic disease with renal cell carcinoma in uremia.
    Wu TH; Tsai CY; Chiang SS; Wang JS; Huang TP; Yu CL
    Nephron; 1994; 67(1):129. PubMed ID: 7993425
    [No Abstract]   [Full Text] [Related]  

  • 24. Massive Subcutaneous Masses on the Back Related to β2-Microglobulin Amyloidosis.
    Gargallo V; Angulo L; Hernández E; Peralto JL; Zarco C
    JAMA Dermatol; 2015 May; 151(5):564-5. PubMed ID: 25607752
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversible pulmonary hypertension and isolated right-sided heart failure associated with hyperthyroidism.
    Ismail HM
    J Gen Intern Med; 2007 Jan; 22(1):148-50. PubMed ID: 17351857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-2-microglobulin-associated amyloidosis.
    Floege J; Ehlerding G
    Nephron; 1996; 72(1):9-26. PubMed ID: 8903856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-2-microglobulin amyloidosis and renal bone disease.
    Drüeke TB
    Miner Electrolyte Metab; 1991; 17(4):261-72. PubMed ID: 1813789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta 2-microglobulin and amyloidosis: who is at risk?
    Davison AM
    Nephrol Dial Transplant; 1995; 10 Suppl 10():48-51. PubMed ID: 8825433
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline].
    Higuchi N; Maruyama H
    Clin Calcium; 2004 May; 14(5):744-9. PubMed ID: 15577036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenetic and diagnostic aspects of dialysis-related amyloidosis.
    Schaeffer J; Floege J; Ehlerding G; Koch KM
    Nephrol Dial Transplant; 1995; 10 Suppl 3():4-8. PubMed ID: 7494614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysis amyloidosis: beta-2-microglobulin in the context of other amyloidogenic proteins.
    Gorevic PD; Munoz P
    Blood Purif; 1988; 6(2):132-44. PubMed ID: 3293617
    [No Abstract]   [Full Text] [Related]  

  • 32. Intraosseous beta-2-microglobulin amyloidosis. Detection and measurement of osseous aluminum in a patient who was receiving long-term hemodialysis.
    Heller DS; Klein MJ; Gordon RE; Good P; Perl D
    J Bone Joint Surg Am; 1989 Aug; 71(7):1083-9. PubMed ID: 2668294
    [No Abstract]   [Full Text] [Related]  

  • 33. Systemic involvement of dialysis-amyloidosis.
    Campistol JM; Solé M; Muñoz-Gomez J; Lopez-Pedret J; Revert L
    Am J Nephrol; 1990; 10(5):389-96. PubMed ID: 2080789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C1Q complexes with beta-2-microglobulin and amyloid P-component in sera of patients with dialysis-associated amyloidosis.
    Hasegawa M; Kawashima S; Shikano M; Kojima K; Yanai T; Hassegawa H; Tomita M; Murakami K; Kawamura N; Katsumata H
    Nephron; 1995; 69(4):380-3. PubMed ID: 7777100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of dialysis amyloid after renal transplantation. A case report.
    Sethi D; Brown EA; Cary NR; Woodrow DF; Gower PE
    Am J Nephrol; 1989; 9(2):173-4. PubMed ID: 2662775
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pathogenesis of dialysis amyloidosis].
    Gejyo F; Hasegawa S; Homma N; Maruyama H; Maruyama S; Arakawa M
    Nihon Rinsho; 1992 Jan; 50 Suppl():796-800. PubMed ID: 1578769
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
    Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
    Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Destructive spondyloarthropathy with beta 2-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis.
    Morinière P; Marie A; el Esper N; Fardellone P; Deramond H; Remond A; Sebert JL; Fournier A
    Nephron; 1991; 59(4):654-7. PubMed ID: 1766508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic approaches to AB-amyloidosis.
    Floege J
    Blood Purif; 1991; 9(2):63-9. PubMed ID: 1760143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mixed systemic amyloidosis in a patient receiving long term haemodialysis.
    Fernandez-Alonso J; Rios-Camacho C; Valenzuela-Castaño A; Hernanz-Mediano W
    J Clin Pathol; 1994 Jun; 47(6):560-1. PubMed ID: 8063944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.